Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene
Authors:
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (2) , 276-280
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Gene therapy for carcinoma of the breastCancer Gene Therapy, 2006
- Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNACancer Gene Therapy, 2005
- A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell SignalingScience, 2005
- Gel-Based Application of siRNA to Human Epithelial Cancer Cells Induces RNAi-Dependent ApoptosisOligonucleotides, 2004
- Gene therapy of uterine leiomyomas: Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude miceAmerican Journal of Obstetrics and Gynecology, 2004
- Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cellsOncogene, 2004
- Physiological and Pathological Consequences of the Interactions of the p53 Tumor Suppressor with the Glucocorticoid, Androgen, and Estrogen ReceptorsAnnals of the New York Academy of Sciences, 2004
- Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: Biologic function and clinical significanceHead & Neck, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Oestrogen Stimulates Differential Transcription of Human Papillomavirus Type 16 in SiHa Cervical Carcinoma CellsJournal of General Virology, 1989